ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 69 filers reported holding ORCHARD THERAPEUTICS PLC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $669 | -99.9% | 1,803,858 | 0.0% | 0.04% | -2.6% |
Q3 2022 | $902,000 | -14.4% | 1,803,858 | 0.0% | 0.04% | -32.1% |
Q2 2022 | $1,054,000 | -17.9% | 1,803,858 | 0.0% | 0.06% | +3.7% |
Q1 2022 | $1,284,000 | -46.1% | 1,803,858 | 0.0% | 0.05% | -16.9% |
Q4 2021 | $2,381,000 | -42.6% | 1,803,858 | 0.0% | 0.06% | -30.1% |
Q3 2021 | $4,149,000 | -47.6% | 1,803,858 | 0.0% | 0.09% | -42.2% |
Q2 2021 | $7,919,000 | -39.5% | 1,803,858 | 0.0% | 0.16% | -30.3% |
Q1 2021 | $13,096,000 | +762.7% | 1,803,858 | +413.2% | 0.23% | +600.0% |
Q4 2020 | $1,518,000 | +5.1% | 351,500 | 0.0% | 0.03% | -5.7% |
Q3 2020 | $1,445,000 | -34.9% | 351,500 | -5.0% | 0.04% | -43.5% |
Q2 2020 | $2,220,000 | -26.3% | 370,000 | -7.5% | 0.06% | -51.2% |
Q1 2020 | $3,012,000 | -37.4% | 400,000 | +14.3% | 0.13% | -31.7% |
Q4 2019 | $4,813,000 | +15.8% | 350,000 | 0.0% | 0.19% | +11.4% |
Q3 2019 | $4,158,000 | -15.1% | 350,000 | 0.0% | 0.17% | -15.7% |
Q2 2019 | $4,897,000 | – | 350,000 | – | 0.20% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |